Table 1 Baseline characteristics
Characteristics (N = 136 DM patients) |  |
|---|---|
Age (years) | 65.3 ± 9.28 |
Women n, (%) | 53 (39.0) |
Body mass index (kg/m2) | 26.94 ± 3.01 |
Blood pressure (mmHg) | |
 Systolic blood pressure | 133.34 ± 15.66 |
 Diastolic blood pressure | 78.98 ± 8.82 |
Risk factors | |
 Hypertention n, (%) | 102 (75.0) |
 Hyperlipidemia n, (%) | 78 (57.4) |
 Smoking n, (%) | 54 (39.7) |
LVEF (%) | 63.79 ± 6.28 |
Clinical presentation | |
 Stable angina n, (%) | 45 (33.1) |
 Unstable angina n, (%) | 63 (46.3) |
 Acute myocardial infarction n, (%) | 24 (17.7) |
 Old myocardial infarction n, (%) | 4 (2.9) |
Target vessels n (%) | |
 LAD | 77 (53.8) |
 LCX | 20 (14.0) |
 RCA | 46 (32.2) |
Laboratory study | |
 Total cholesterol (mmol/L) | 4.27 ± 1.00 |
 Triglycerides (mmol/L) | 2.18 ± 1.27 |
 HDL-C (mmol/L) | 1.08 ± 0.25 |
 LDL-C (mmol/L) | 2.42 ± 0.85 |
 Apo-A (mmol/L) | 1.13 ± 0.18 |
 Apo-B (mmol/L) | 0.90 ± 0.22 |
 Lp (a) (g/L) | 0.19 ± 0.15 |
 Fast glucose (mmol/L) | 7.55 ± 2.50 |
 BUN (mmol/L) | 5.98 ± 1.65 |
 Creatinine (mg/L) | 86.19 ± 24.58 |
 Glycated haemoglobin (%) | 7.84 ± 1.51 |
 hsCRP (mg/L) | 5.47 ± 6.11 |
 esRAGE (ng/ml) | 0.20 ± 0.15 |
 GA (%) | 21.63 ± 5.54 |
Oral hypoglycemic agents n, (%) | 112 (82.4) |
Insulin n, (%) | 31 (22.8) |
Duration of DM treatment (years) | 11.2 ± 8.5 |
Antiplatalet n, (%) | 136 (100) |
Statins n, (%) | 132 (97.1) |